cgmp guidelines Options
No. 21 CFR 211.113(a) requires acceptable written strategies for being established and adopted during manufacturing to stop objectionable microorganisms in drug items not needed to be sterile. Also, the 2nd paragraph of USP Basic Chapter Antimicrobial Usefulness Testing reads: Antimicrobial preservatives should not be made use of instead p